Drugmaker Pfizer Inc. said Wednesday its second-quarter profit fell 48% year-over-year, hurt by the loss of patent exclusivity for its Zoloft and Norvasc drugs and by sluggish sales of blockbuster cholesterol drug, Lipitor, in the United States.
*For more on this story,
read the full Associated Press article.
